About Us
Sarcomed AB is a biotech company focused on developing treatments for rare muscular dystrophies, holding 14 FDA orphan drug designations. We specialize in advancing repurposed compounds to accelerate patient access to innovative therapies for rare neuromuscular diseases.
Products & Services
Beyond drug development, Sarcomed provides regulatory consulting services to support biotech companies in navigating complex approval pathways. Our services include:
- Orphan Drug Designation (ODD) applications for FDA and EMA
- Pre-IND meeting preparation and strategy
- Biomarker validation support
- CDMO business development freelance services
With expertise in regulatory strategy and rare disease drug development, we help bring promising therapies closer to patients in need.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sarcomed.com
Sarcomed Ab Questions
Sarcomed Ab's website is http://www.sarcomed.com
Sarcomed Ab's LinkedIn profile is https://www.linkedin.com/company/sarcomed-ab
Sarcomed Ab has
1 employees.
View email and phone details for 1
employees at Sarcomed Ab.
Sarcomed Ab's industry is
Biotechnology Research
Sarcomed Ab's top competitors are
One Acre Fund,
Wildbrain Cplg,
Datapharm,
Path,
Zenopa,
Amref Health Africa,
Applied Biopharm Consulting.
Sarcomed Ab's categories are Biotechnology Research
Sarcomed Ab's founding year is 2014
